acquired
Stage
2
Investors
About
Optonol Ltd. was an Israel-based medical device company that developed the Ex-Press™ microscopic glaucoma shunt to reduce intraocular pressure in glaucoma patients. The company focused on ophthalmic surgical implants and was reported to have been acquired by larger ophthalmology firms (Alcon/Novartis).
Explore Optonol Ltd.'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.